SIK1-LNC represses the proliferative, migrative, and invasive abilities of lung cancer cells
Received 11 February 2018
Accepted for publication 30 May 2018
Published 19 July 2018 Volume 2018:11 Pages 4197—4206
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Justinn Cochran
Peer reviewer comments 3
Editor who approved publication: Dr Jianmin Xu
Liu Yang,1,* Nianlin Xie,2,* Jingyu Huang,3,* Hu Huang,4,* Shaogan Xu,5 Zhigang Wang,4 Jun Cai6
1Department of Cancer Biotherapy Center, Hubei Cancer Hospital, Wuhan 430079, Hubei, People’s Republic of China; 2Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi’an 710038, Shaanxi, People’s Republic of China; 3Department of Thoracic and Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, People’s Republic of China; 4Department of Oncology, The 161th Hospital of PLA, Wuhan, Hubei 430010, People’s Republic of China; 5Department of Thoracic Surgery, The 161th Hospital of PLA, Wuhan, Hubei 430010, People’s Republic of China; 6Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei, People’s Republic of China
*These authors contributed equally to this work
Background: Discussions regarding the correlations between long non-coding RNAs (lncRNAs) and cancers have dominated research in recent years. SIK1-LNC, a type of lncRNA and adjacent to salt-inducible kinases 1 (SIK1), has been found aberrantly expressed in lung cancer. However, its functional role in lung cancer remains largely unknown.
Purpose: In this study, we aimed to explore the association between SIK1-LNC expression and SIK1 in lung cancer cells and further identify the impact of SIK1-LNC on the proliferation, migration invasion of lung cancer cells.
Patients and methods: Of the 30 patients with non-small-cell lung carcinoma from Zhongnan Hospital of Wuhan University, RT-qPCR was performed to detect SIK1 and SIK1-LNC expressions in patients’ samples. Overexpression and knockdown experiments were conducted to analyze the SIK1 and SIK1-LNC expressions in lung cancer cell lines. CCK-8, Brdu, scratch wound-healing, and Transwell assays were respectively employed to evaluate the proliferative, migrative, and invasive abilities of lung cancer cells.
Results: Both SIK1-LNC and SIK1 expression levels were evidently downregulated in 30 lung cancer tissues. SIK1-LNC expression was bound up with clinicopathologic features, including lymph node metastasis and distant metastasis. SIK1 expression showed a positive tendency with SIK1-LNC expression in lung cancer cells. SIK1-LNC exerted a significant repression on cell proliferatiive, miogrative and invasive abilities of lung cancer cells.
Conclusion: Our findings suggested that SIK1-LNC may act as a novel biomarker and therapeutic target for lung cancer.
Keywords: lung cancer, SIK1-LNC, SIK1, proliferation, invasion, metastasis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]